Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4796809
Max Phase: Preclinical
Molecular Formula: C46H54IN5O3
Molecular Weight: 851.87
Molecule Type: Unknown
Associated Items:
ID: ALA4796809
Max Phase: Preclinical
Molecular Formula: C46H54IN5O3
Molecular Weight: 851.87
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCc1cccc(I)c1)[C@@H]3C
Standard InChI: InChI=1S/C46H54IN5O3/c1-8-10-11-12-18-55-29(7)43-27(5)37-21-36-26(4)33(16-17-42(54)48-24-30-14-13-15-31(47)19-30)45(51-36)34-20-41(53)44-28(6)38(52-46(34)44)22-39-32(9-2)25(3)35(49-39)23-40(43)50-37/h13-15,19,21-23,26,29,33,50,52H,8-12,16-18,20,24H2,1-7H3,(H,48,54)/b35-23-,36-21-,37-21-,38-22-,39-22-,40-23-,45-34-/t26-,29?,33-/m0/s1
Standard InChI Key: NDDIQPUSTCYFSQ-FEZDDJJHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 851.87 | Molecular Weight (Monoisotopic): 851.3271 | AlogP: 11.26 | #Rotatable Bonds: 13 |
Polar Surface Area: 112.76 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.31 | CX Basic pKa: 5.00 | CX LogP: 10.99 | CX LogD: 10.99 |
Aromatic Rings: 4 | Heavy Atoms: 55 | QED Weighted: 0.09 | Np Likeness Score: 0.38 |
1. Cheruku RR,Cacaccio J,Durrani FA,Tabaczynski WA,Watson R,Siters K,Missert JR,Tracy EC,Dukh M,Guru K,Koya RC,Kalinski P,Baumann H,Pandey RK. (2021) Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer., 64 (1.0): [PMID:33400524] [10.1021/acs.jmedchem.0c01735] |
Source(1):